Actuate Corporation Misses Estimates by 7 cents; Petr Hits New Yearly High


Follow this company

Companies Mentioned

NYSE:PBR / NASDAQ:WPRT / NASDAQ:BIRT / PK:CHBO
05/05/2014 [ACCESSWIRE]

Petr (NYSE: PBR) - For an in-depth report on Petr follow: www.BullTrends.com/stockquote/PBR

Shares of PBR closed up 6.18% on nearly 32 million shares traded. The stock was one of the biggest gainers on the NYSE and hit a new yearly high, despite no significant news released from the company. Petrobras operates as an integrated oil and gas company in Brazil and internationally.

Westport Innovations Inc. (NASDAQ: WPRT) - For an in-depth report on Westport Innovations Inc..follow: www.BullTrends.com/stockquote/WPRT

Shares of Westport Innovations Inc. closed up nearly 25% on Friday with about 7.1 million shares traded. The stock was one of the biggest gainers on the NASDAQ. The company released their first quarter earnings report and posted a year over year quarterly revenue increase of 39% to $41.9 million, whicih beat analysts’ estimates of $41.3 million.

Actuate Corporation (NASDAQ: BIRT) - For an in-depth report on Actuate Corporation follow: www.BullTrends.com/stockquote/BIRT

Shares of Actuate Corporation closed down 27.91% on about 10 million shares traded. The stock was one of the biggest decliners on the NASDAQ and hit a new yearly low of $3.41 during intra-day trading.  The company missed analysts’ expectations for earnings and revenue in the first quarter. For Q1 Actuate posted a loss of -1 cent a share, missing the Capital IQ Consensus of earnings of 6 cents a share by 7 cents.

China Biopharma, Inc. (OTC: CHBO) - For an in-depth report on China Biopharma, Inc. follow: www.BullTrends.com/stockquote/CHBO

Shares of CHBO closed up 250% on Friday making it one of the biggest gainers in the OTC market. The stock traded 45 million shares despite no significant news from the company. The company engages in the development and marketing of human vaccines and other pharmaceutical products in the People's Republic of China.

 

Disclosure: BullTrends.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures.

COMMENTS

Leave a comment...
 * 

Your Name
 *